Aristopharma Ltd. has introduced "Cozopt SUD," a preparation of 100% preservative-free Dorzolamide 2% & Timolol 0.5% ophthalmic solution in single-unit dosage form for treatment of glaucoma.

Cozopt SUD is manufactured from EU GMP approved largest ophthalmic plant in Banglasdesh with USA technology from Weiler, as well as European-sourced resin pellets from Germany, ensuring the optimum quality of the product. It ensures a high degree of product sterility assurance. It is manufactured in a Re-closable vial, ensures convenience & less wastage, while daily use; thus, reduces unnecessary costs at a time. It is a CAI-Beta blocker combination. Dorzolamide is a carbonic anhydrase II inhibitor which decreases aqueous humor production by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Timolol is a non-selective beta-adrenergic receptor blocker that lowers IOP by decreasing the formation of aqueous humor in the ciliary epithelium.